Fabrication of polymer-based self-assembly nanocarriers loaded with a crizotinib and gemcitabine: potential therapeutics for the treatment of endometrial cancer.

Yang, Jiaolin; Guo, Hongrui; Lei, Jing; Zhang, Sanyuan; Zhang, Shaoguo; Bai, Jirong; Li, Sufen

Yang, Jiaolin; Guo, Hongrui; Lei, Jing; Zhang, Sanyuan; Zhang, Shaoguo; Bai, Jirong; Li, Sufen.

Afiliação

Yang J; Department of Gynecology, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Guo H; Department of Gynecology, Yuncheng Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi Province, China.
Lei J; Department of Gynecology, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Zhang S; Department of Gynecology, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Zhang S; Department of Nursing Care, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Bai J; Department of Gynecology, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Li S; Department of Gynecology, the First Hospital of Shanxi Medical University, Taiyuan, Shanxi Province, China.

J Biomater Sci Polym Ed ; 33(1): 20-34, 2022 01.

Article em En | MEDLINE | ID: mdl-34602004

Assuntos

Neoplasias do Endométrio; Nanopartículas; Crizotinibe; Desoxicitidina/análogos & derivados; Portadores de Fármacos; Neoplasias do Endométrio/tratamento farmacológico; Feminino; Humanos; Poliésteres; Polietilenoglicóis; Polímeros; Gencitabina

Palavras-chave

Combinational delivery; apoptosis; endometrial cancer; in vivo systemic toxicity; mitochondrial assay

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Nanopartículas Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google